Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Telatinib |
Synonyms | |
Therapy Description |
Telatinib (BAY 57-9352) inhibits VEGFR2, VEGFR3, PDGFR-beta (PDGFRB), and KIT, which may result in decreased proliferation and angiogenesis in tumors expressing these factors (PMID: 29511030). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Telatinib | BAY 57-9352 | KIT Inhibitor 57 PDGFR-beta Inhibitor 14 VEGFR2 Inhibitor 37 VEGFR3 Inhibitor 6 | Telatinib (BAY 57-9352) inhibits VEGFR2, VEGFR3, PDGFR-beta (PDGFRB), and KIT, which may result in decreased proliferation and angiogenesis in tumors expressing these factors (PMID: 29511030). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|